DXCM logo

DXCM
Dexcom Inc

9,992
Mkt Cap
$27.91B
Volume
9.26M
52W High
$89.98
52W Low
$54.11
PE Ratio
31.54
DXCM Fundamentals
Price
$73.74
Prev Close
$72.34
Open
$72.89
50D MA
$63.91
Beta
0.82
Avg. Volume
4.25M
EPS (Annual)
$2.09
P/B
9.62
Rev/Employee
$420,000.00
$26,304.04
Loading...
Loading...
News
all
press releases
PODD Stock: What a Hold Rating Says at a $163 Target
Insulet earns a short-term Hold as outlook rises; a $163 sales-based target tests whether growth can beat 2026 volatility.
Zacks
News Placeholder
More News
News Placeholder
PODD and Omnipod 5: What's Driving Insulet's 2026 Growth
Insulet's Omnipod 5 drives a Q1 beat and raised 2026 outlook as upgrades and global rollout expand access - while correction costs loom.
Zacks
News Placeholder
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
News Placeholder
Signos raises $20M, expands Dexcom partnership for weight loss
Signos raises $20M, expands Dexcom partnership for weight loss...
Yahoo! Finance: News
News Placeholder
Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking
Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical device giant Dexcom...
CNBC: Healthcare
News Placeholder
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
read more...
Benzinga
News Placeholder
Here's Why DexCom (DXCM) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
DXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in Germany
DexCom gains 5.6% after announcing plans to launch Dexcom Flex in Germany, expanding CGM access for Type 2 diabetes patients using basal insulin or oral meds.
Zacks
News Placeholder
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany
DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today announced Dexcom Flex, a new CGM system designed specifically for adults with Type 2 diabetes who are not using...
Business Wire
News Placeholder
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day...
Yahoo! Finance: News
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available